Cortical interneuron loss and symptom heterogeneity in Huntington disease

Objective The cellular basis of variable symptoms in Huntington disease (HD) is unclear. One important possibility is that degeneration of the interneurons in the cerebral cortex, which play a critical role in modulating cortical output to the basal ganglia, might play a significant role in the deve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of neurology 2014-05, Vol.75 (5), p.717-727
Hauptverfasser: Kim, Eric H., Thu, Doris C. V., Tippett, Lynette J., Oorschot, Dorothy E., Hogg, Virginia M., Roxburgh, Richard, Synek, Beth J., Waldvogel, Henry J., Faull, Richard L. M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 727
container_issue 5
container_start_page 717
container_title Annals of neurology
container_volume 75
creator Kim, Eric H.
Thu, Doris C. V.
Tippett, Lynette J.
Oorschot, Dorothy E.
Hogg, Virginia M.
Roxburgh, Richard
Synek, Beth J.
Waldvogel, Henry J.
Faull, Richard L. M.
description Objective The cellular basis of variable symptoms in Huntington disease (HD) is unclear. One important possibility is that degeneration of the interneurons in the cerebral cortex, which play a critical role in modulating cortical output to the basal ganglia, might play a significant role in the development of variable symptomatology in HD. This study aimed to examine whether symptom variability in HD is specifically associated with variable degeneration of cortical interneurons. Methods We undertook a double‐blind study using stereological cell counting methods to quantify the 3 major types of γ‐aminobutyric acidergic interneurons (calbindin‐D28k, calretinin, parvalbumin) in 13 HD cases of variable motor/mood symptomatology and 15 matched control cases in the primary motor and anterior cingulate cortices. Results In the primary motor cortex, there was a significant loss (57% reduction) of only calbindin interneurons (p = 0.022) in HD cases dominated by motor symptoms, but no significant interneuron loss in cases with a dominant mood phenotype. In contrast, the anterior cingulate cortex showed a major significant loss in all 3 interneuron populations, with 71% loss of calbindin (p = 0.001), 60% loss of calretinin (p = 0.001), and 80% loss of parvalbumin interneurons (p = 0.005) in HD cases with major mood disorder, and no interneuron loss was observed in cases with major motor dysfunction. Interpretation These findings suggest that region‐specific degeneration of cortical interneurons is a key component in understanding the neural basis of symptom heterogeneity in HD. Ann Neurol 2014;75:717–727
doi_str_mv 10.1002/ana.24162
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1540232612</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1534792720</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4902-b29a0ca589b79f4f98f40103a35cfcd184fbf8422ce5891635f7456d7957c6d13</originalsourceid><addsrcrecordid>eNqN0btOHDEUBmALBcGGUPAC0UhpSDFgH9_G5WoVbiJQJAGJxvJ6bGIy49nYM0r27eOwQBEJKZWL851f8n8QOiD4iGAMxyaaI2BEwBaaEU5J3QBTb9AMU8FqTijbRW9zfsAYK0HwDtoFJiUpgxk6XwxpDNZ0VYijS9FNaYhVN-RcmdhWed2vxqGvvrsyHO5ddGFcF1qdTXEM8X4suA3ZmezeoW1vuuz2n9499O3k09fFWX15fXq-mF_WlikM9RKUwdbwRi2l8syrxjNMMDWUW29b0jC_9A0DsK4YIij3knHRSsWlFS2he-hwk7tKw8_J5VH3IVvXdSa6YcqacIaBgiDwH5QyqUACLvTDP_RhmFIsH3lUAFC6K-rjRtlUGkrO61UKvUlrTbD-ewpdTqEfT1Hs-6fEadm79kU-d1_A8Qb8Cp1bv56k51fz58h6sxHy6H6_bJj0QwtJJde3V6da3H2GL_j2Rl_QP1R_oBI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1534222096</pqid></control><display><type>article</type><title>Cortical interneuron loss and symptom heterogeneity in Huntington disease</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kim, Eric H. ; Thu, Doris C. V. ; Tippett, Lynette J. ; Oorschot, Dorothy E. ; Hogg, Virginia M. ; Roxburgh, Richard ; Synek, Beth J. ; Waldvogel, Henry J. ; Faull, Richard L. M.</creator><creatorcontrib>Kim, Eric H. ; Thu, Doris C. V. ; Tippett, Lynette J. ; Oorschot, Dorothy E. ; Hogg, Virginia M. ; Roxburgh, Richard ; Synek, Beth J. ; Waldvogel, Henry J. ; Faull, Richard L. M.</creatorcontrib><description>Objective The cellular basis of variable symptoms in Huntington disease (HD) is unclear. One important possibility is that degeneration of the interneurons in the cerebral cortex, which play a critical role in modulating cortical output to the basal ganglia, might play a significant role in the development of variable symptomatology in HD. This study aimed to examine whether symptom variability in HD is specifically associated with variable degeneration of cortical interneurons. Methods We undertook a double‐blind study using stereological cell counting methods to quantify the 3 major types of γ‐aminobutyric acidergic interneurons (calbindin‐D28k, calretinin, parvalbumin) in 13 HD cases of variable motor/mood symptomatology and 15 matched control cases in the primary motor and anterior cingulate cortices. Results In the primary motor cortex, there was a significant loss (57% reduction) of only calbindin interneurons (p = 0.022) in HD cases dominated by motor symptoms, but no significant interneuron loss in cases with a dominant mood phenotype. In contrast, the anterior cingulate cortex showed a major significant loss in all 3 interneuron populations, with 71% loss of calbindin (p = 0.001), 60% loss of calretinin (p = 0.001), and 80% loss of parvalbumin interneurons (p = 0.005) in HD cases with major mood disorder, and no interneuron loss was observed in cases with major motor dysfunction. Interpretation These findings suggest that region‐specific degeneration of cortical interneurons is a key component in understanding the neural basis of symptom heterogeneity in HD. Ann Neurol 2014;75:717–727</description><identifier>ISSN: 0364-5134</identifier><identifier>EISSN: 1531-8249</identifier><identifier>DOI: 10.1002/ana.24162</identifier><identifier>PMID: 24771513</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Brain ; Cell Count - methods ; Cerebral Cortex - pathology ; Double-Blind Method ; Female ; Humans ; Huntington Disease - diagnosis ; Huntington Disease - epidemiology ; Huntington Disease - pathology ; Interneurons - pathology ; Male ; Middle Aged</subject><ispartof>Annals of neurology, 2014-05, Vol.75 (5), p.717-727</ispartof><rights>2014 American Neurological Association</rights><rights>2014 American Neurological Association.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4902-b29a0ca589b79f4f98f40103a35cfcd184fbf8422ce5891635f7456d7957c6d13</citedby><cites>FETCH-LOGICAL-c4902-b29a0ca589b79f4f98f40103a35cfcd184fbf8422ce5891635f7456d7957c6d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fana.24162$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fana.24162$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24771513$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Eric H.</creatorcontrib><creatorcontrib>Thu, Doris C. V.</creatorcontrib><creatorcontrib>Tippett, Lynette J.</creatorcontrib><creatorcontrib>Oorschot, Dorothy E.</creatorcontrib><creatorcontrib>Hogg, Virginia M.</creatorcontrib><creatorcontrib>Roxburgh, Richard</creatorcontrib><creatorcontrib>Synek, Beth J.</creatorcontrib><creatorcontrib>Waldvogel, Henry J.</creatorcontrib><creatorcontrib>Faull, Richard L. M.</creatorcontrib><title>Cortical interneuron loss and symptom heterogeneity in Huntington disease</title><title>Annals of neurology</title><addtitle>Ann Neurol</addtitle><description>Objective The cellular basis of variable symptoms in Huntington disease (HD) is unclear. One important possibility is that degeneration of the interneurons in the cerebral cortex, which play a critical role in modulating cortical output to the basal ganglia, might play a significant role in the development of variable symptomatology in HD. This study aimed to examine whether symptom variability in HD is specifically associated with variable degeneration of cortical interneurons. Methods We undertook a double‐blind study using stereological cell counting methods to quantify the 3 major types of γ‐aminobutyric acidergic interneurons (calbindin‐D28k, calretinin, parvalbumin) in 13 HD cases of variable motor/mood symptomatology and 15 matched control cases in the primary motor and anterior cingulate cortices. Results In the primary motor cortex, there was a significant loss (57% reduction) of only calbindin interneurons (p = 0.022) in HD cases dominated by motor symptoms, but no significant interneuron loss in cases with a dominant mood phenotype. In contrast, the anterior cingulate cortex showed a major significant loss in all 3 interneuron populations, with 71% loss of calbindin (p = 0.001), 60% loss of calretinin (p = 0.001), and 80% loss of parvalbumin interneurons (p = 0.005) in HD cases with major mood disorder, and no interneuron loss was observed in cases with major motor dysfunction. Interpretation These findings suggest that region‐specific degeneration of cortical interneurons is a key component in understanding the neural basis of symptom heterogeneity in HD. Ann Neurol 2014;75:717–727</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Brain</subject><subject>Cell Count - methods</subject><subject>Cerebral Cortex - pathology</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Humans</subject><subject>Huntington Disease - diagnosis</subject><subject>Huntington Disease - epidemiology</subject><subject>Huntington Disease - pathology</subject><subject>Interneurons - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><issn>0364-5134</issn><issn>1531-8249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0btOHDEUBmALBcGGUPAC0UhpSDFgH9_G5WoVbiJQJAGJxvJ6bGIy49nYM0r27eOwQBEJKZWL851f8n8QOiD4iGAMxyaaI2BEwBaaEU5J3QBTb9AMU8FqTijbRW9zfsAYK0HwDtoFJiUpgxk6XwxpDNZ0VYijS9FNaYhVN-RcmdhWed2vxqGvvrsyHO5ddGFcF1qdTXEM8X4suA3ZmezeoW1vuuz2n9499O3k09fFWX15fXq-mF_WlikM9RKUwdbwRi2l8syrxjNMMDWUW29b0jC_9A0DsK4YIij3knHRSsWlFS2he-hwk7tKw8_J5VH3IVvXdSa6YcqacIaBgiDwH5QyqUACLvTDP_RhmFIsH3lUAFC6K-rjRtlUGkrO61UKvUlrTbD-ewpdTqEfT1Hs-6fEadm79kU-d1_A8Qb8Cp1bv56k51fz58h6sxHy6H6_bJj0QwtJJde3V6da3H2GL_j2Rl_QP1R_oBI</recordid><startdate>201405</startdate><enddate>201405</enddate><creator>Kim, Eric H.</creator><creator>Thu, Doris C. V.</creator><creator>Tippett, Lynette J.</creator><creator>Oorschot, Dorothy E.</creator><creator>Hogg, Virginia M.</creator><creator>Roxburgh, Richard</creator><creator>Synek, Beth J.</creator><creator>Waldvogel, Henry J.</creator><creator>Faull, Richard L. M.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201405</creationdate><title>Cortical interneuron loss and symptom heterogeneity in Huntington disease</title><author>Kim, Eric H. ; Thu, Doris C. V. ; Tippett, Lynette J. ; Oorschot, Dorothy E. ; Hogg, Virginia M. ; Roxburgh, Richard ; Synek, Beth J. ; Waldvogel, Henry J. ; Faull, Richard L. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4902-b29a0ca589b79f4f98f40103a35cfcd184fbf8422ce5891635f7456d7957c6d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Brain</topic><topic>Cell Count - methods</topic><topic>Cerebral Cortex - pathology</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Humans</topic><topic>Huntington Disease - diagnosis</topic><topic>Huntington Disease - epidemiology</topic><topic>Huntington Disease - pathology</topic><topic>Interneurons - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Eric H.</creatorcontrib><creatorcontrib>Thu, Doris C. V.</creatorcontrib><creatorcontrib>Tippett, Lynette J.</creatorcontrib><creatorcontrib>Oorschot, Dorothy E.</creatorcontrib><creatorcontrib>Hogg, Virginia M.</creatorcontrib><creatorcontrib>Roxburgh, Richard</creatorcontrib><creatorcontrib>Synek, Beth J.</creatorcontrib><creatorcontrib>Waldvogel, Henry J.</creatorcontrib><creatorcontrib>Faull, Richard L. M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Eric H.</au><au>Thu, Doris C. V.</au><au>Tippett, Lynette J.</au><au>Oorschot, Dorothy E.</au><au>Hogg, Virginia M.</au><au>Roxburgh, Richard</au><au>Synek, Beth J.</au><au>Waldvogel, Henry J.</au><au>Faull, Richard L. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cortical interneuron loss and symptom heterogeneity in Huntington disease</atitle><jtitle>Annals of neurology</jtitle><addtitle>Ann Neurol</addtitle><date>2014-05</date><risdate>2014</risdate><volume>75</volume><issue>5</issue><spage>717</spage><epage>727</epage><pages>717-727</pages><issn>0364-5134</issn><eissn>1531-8249</eissn><abstract>Objective The cellular basis of variable symptoms in Huntington disease (HD) is unclear. One important possibility is that degeneration of the interneurons in the cerebral cortex, which play a critical role in modulating cortical output to the basal ganglia, might play a significant role in the development of variable symptomatology in HD. This study aimed to examine whether symptom variability in HD is specifically associated with variable degeneration of cortical interneurons. Methods We undertook a double‐blind study using stereological cell counting methods to quantify the 3 major types of γ‐aminobutyric acidergic interneurons (calbindin‐D28k, calretinin, parvalbumin) in 13 HD cases of variable motor/mood symptomatology and 15 matched control cases in the primary motor and anterior cingulate cortices. Results In the primary motor cortex, there was a significant loss (57% reduction) of only calbindin interneurons (p = 0.022) in HD cases dominated by motor symptoms, but no significant interneuron loss in cases with a dominant mood phenotype. In contrast, the anterior cingulate cortex showed a major significant loss in all 3 interneuron populations, with 71% loss of calbindin (p = 0.001), 60% loss of calretinin (p = 0.001), and 80% loss of parvalbumin interneurons (p = 0.005) in HD cases with major mood disorder, and no interneuron loss was observed in cases with major motor dysfunction. Interpretation These findings suggest that region‐specific degeneration of cortical interneurons is a key component in understanding the neural basis of symptom heterogeneity in HD. Ann Neurol 2014;75:717–727</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>24771513</pmid><doi>10.1002/ana.24162</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0364-5134
ispartof Annals of neurology, 2014-05, Vol.75 (5), p.717-727
issn 0364-5134
1531-8249
language eng
recordid cdi_proquest_miscellaneous_1540232612
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Aged
Aged, 80 and over
Brain
Cell Count - methods
Cerebral Cortex - pathology
Double-Blind Method
Female
Humans
Huntington Disease - diagnosis
Huntington Disease - epidemiology
Huntington Disease - pathology
Interneurons - pathology
Male
Middle Aged
title Cortical interneuron loss and symptom heterogeneity in Huntington disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T05%3A42%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cortical%20interneuron%20loss%20and%20symptom%20heterogeneity%20in%20Huntington%20disease&rft.jtitle=Annals%20of%20neurology&rft.au=Kim,%20Eric%20H.&rft.date=2014-05&rft.volume=75&rft.issue=5&rft.spage=717&rft.epage=727&rft.pages=717-727&rft.issn=0364-5134&rft.eissn=1531-8249&rft_id=info:doi/10.1002/ana.24162&rft_dat=%3Cproquest_cross%3E1534792720%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1534222096&rft_id=info:pmid/24771513&rfr_iscdi=true